- Filed
- Nov 13, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Nov 10, 2025 | 4.24M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 3.16M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 2.11M sh |
| Shares Diluted restated | Q3 2025 · Sep 30, 2024 | 1.33M sh |
| Shares Diluted restated | Q3 2025 · Sep 30, 2024 | 1.18M sh |
| Operating Cash Flow | Q3 2025 · Sep 30, 2025 | −$18.77M |
| Operating Cash Flow | Q3 2025 · Sep 30, 2024 | −$36.67M |
| Cash And Equivalents | Q3 2025 · Sep 30, 2025 | $12.55M |
| Cash And Equivalents | Q3 2025 · Dec 31, 2024 | $23.29M |
| Stockholders Equity | Q3 2025 · Sep 30, 2025 | $8M |
| Stockholders Equity | Q3 2025 · Jun 30, 2025 | $6.09M |
| Stockholders Equity | Q3 2025 · Mar 31, 2025 | $8.25M |
| Stockholders Equity | Q3 2025 · Dec 31, 2024 | $14.29M |
| Stockholders Equity | Q3 2025 · Sep 30, 2024 | $15.16M |
| Stockholders Equity | Q3 2025 · Jun 30, 2024 | $12.38M |
| Stockholders Equity | Q3 2025 · Mar 31, 2024 | $12.5M |
| Stockholders Equity | Q3 2025 · Dec 31, 2023 | −$15.16M |
| Current Liabilities | Q3 2025 · Sep 30, 2025 | $4.91M |
| Current Liabilities | Q3 2025 · Dec 31, 2024 | $9.39M |
| Total Liabilities | Q3 2025 · Sep 30, 2025 | $5.25M |
| Total Liabilities | Q3 2025 · Dec 31, 2024 | $9.8M |
| Current Assets | Q3 2025 · Sep 30, 2025 | $13.62M |
| Current Assets | Q3 2025 · Dec 31, 2024 | $24.25M |
| Total Assets | Q3 2025 · Sep 30, 2025 | $14.63M |
| Total Assets | Q3 2025 · Dec 31, 2024 | $25.47M |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −$1.41 |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −$7.82 |
| Eps Diluted restated | Q3 2025 · Sep 30, 2024 | −$12.13 |
| Eps Diluted restated | Q3 2025 · Sep 30, 2024 | −$41.79 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −$1.41 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −$7.82 |
| Eps Basic restated | Q3 2025 · Sep 30, 2024 | −$11.18 |
| Eps Basic restated | Q3 2025 · Sep 30, 2024 | −$36.35 |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $2.33M |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $8.95M |
| Sga Expense | Q3 2025 · Sep 30, 2024 | $7.83M |
| Sga Expense | Q3 2025 · Sep 30, 2024 | $19.11M |
| Rd Expense | Q3 2025 · Sep 30, 2025 | $2.52M |
| Rd Expense | Q3 2025 · Sep 30, 2025 | $8.34M |
| Rd Expense | Q3 2025 · Sep 30, 2024 | $5.49M |
| Rd Expense | Q3 2025 · Sep 30, 2024 | $19.93M |
| Net Income | Q3 2025 · Sep 30, 2025 | −$4.44M |
| Net Income | Q3 2025 · Sep 30, 2025 | −$16.5M |
| Net Income | Q3 2025 · Jun 30, 2025 | −$5.45M |
| Net Income | Q3 2025 · Mar 31, 2025 | −$6.6M |
| Net Income | Q3 2025 · Sep 30, 2024 | −$14.66M |
| Net Income | Q3 2025 · Sep 30, 2024 | −$42.23M |
| Net Income | Q3 2025 · Jun 30, 2024 | −$919.37K |
| Net Income | Q3 2025 · Mar 31, 2024 | −$26.64M |
| Operating Income | Q3 2025 · Sep 30, 2025 | −$4.85M |
| Operating Income | Q3 2025 · Sep 30, 2025 | −$17.29M |
| Operating Income | Q3 2025 · Sep 30, 2024 | −$13.33M |
| Operating Income | Q3 2025 · Sep 30, 2024 | −$39.03M |
| Capex | Q3 2025 · Sep 30, 2024 | $42.91K |